Sonendo, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

OTC.Pink
Sonendo, Inc. reports its 2024 financial results, including a net loss of $33.5 million, and announces the suspension of its SEC reporting obligations.
OTC.Pink
Sonendo, Inc. reports a net loss of $60.9 million on revenue of $43.9 million for 2023, while divesting its software segment to focus on its core medical technology business.